drugset / Trial / NCT05355935
A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants
RandomizedCrossoverQuadruple-blindTreatment
Summary
The study has 2 Parts: The primary purpose of Part 1 is to determine the supratherapeutic dose of brensocatib to be used in Part 2 of the study. The primary purpose of Part 2 is to assess brensocatib's potential for prolonging the QT interval.
Timeline
- Start
- 2022-04-27
- Primary completion
- 2022-10-07
- Completion
- 2022-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brensocatib | Small molecule | — | Oral |
| Subject | Moxifloxacin | Small molecule | — | Oral |
Indications
No indication recorded.